Select Publications
Journal articles
2018, '226 Summary of baricitinib effect on patient-reported outcomes (PROs) in methotrexate-inadequate responder patient population', Rheumatology, 57, http://dx.doi.org/10.1093/rheumatology/key075.450
,2018, 'Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis', Clinical Rheumatology, 37, pp. 383 - 388, http://dx.doi.org/10.1007/s10067-017-3895-z
,2018, 'AC-CUTE: An Open-Label Study to Evaluate Progression of Structural Joint Damage and Inflammation in Subjects with Moderate to Severe Rheumatoid Arthritis', International Journal of Rheumatology, 2018, pp. 8721753, http://dx.doi.org/10.1155/2018/8721753
,2018, 'Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: A multi-centre Australian study', International Journal of Rheumatic Diseases, 21, pp. 510 - 516, http://dx.doi.org/10.1111/1756-185X.13127
,2017, 'Vertebroplasty for acute painful osteoporotic fracture', Medical Journal of Australia, 207, pp. 279 - 281.e1, http://dx.doi.org/10.5694/mja16.01423
,2017, 'Criticisms of the VAPOUR trial in a recent commentary are unsubstantiated and incorrect', Evidence-Based Medicine, 22, pp. 116 - 117, http://dx.doi.org/10.1136/ebmed-2017-110737
,2017, 'Longitudinal study of clinical prognostic factors in patients with early rheumatoid arthritis: the PREDICT study', International Journal of Rheumatic Diseases, 20, pp. 460 - 468, http://dx.doi.org/10.1111/1756-185X.13036
,2017, 'Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)', Annals of the Rheumatic Diseases, 76, pp. 694 - 700, http://dx.doi.org/10.1136/annrheumdis-2016-209821
,2017, 'Consensus statements on the imaging of axial spondyloarthritis in Australia and New Zealand', Journal of Medical Imaging and Radiation Oncology, 61, pp. 58 - 69, http://dx.doi.org/10.1111/1754-9485.12573
,2017, 'The CEDAR Study: A longitudinal study of the clinical effects of conventional DMARDs and biologic DMARDs in Australian rheumatology practice', International Journal of Rheumatology, 2017, pp. 1201450, http://dx.doi.org/10.1155/2017/1201450
,2017, 'A randomised double-blind placebo-controlled crossover trial of humira (adalimumab) for erosive hand osteoarthritis: the humor trial', Osteoarthritis and Cartilage, 25, pp. S9 - S9, http://dx.doi.org/10.1016/j.joca.2017.02.032
,2016, 'Apremilast monotherapy as the first systemic treatment in DMARD-naive patients with active psoriatic arthritis: 3-year treatment results', Revue du Rhumatisme (Edition Francaise), 83, pp. A249, http://dx.doi.org/10.1016/S1169-8330(16)30589-0
,2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 Phase III, randomized, controlled trials', Revue du Rhumatisme (Edition Francaise), 83, pp. A248 - A249, http://dx.doi.org/10.1016/S1169-8330(16)30588-9
,2016, 'Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: A phase III, randomised, controlled trial (PALACE 3)', Annals of the Rheumatic Diseases, 75, pp. 1065 - 1073, http://dx.doi.org/10.1136/annrheumdis-2015-207963
,, 2016, '194 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (104 Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from Three Phase III Randomized Controlled Trials', Rheumatology, http://dx.doi.org/10.1093/rheumatology/kew145.005
2016, 'Evaluation of magnetic resonance imaging responsiveness in active psoriatic arthritis at multiple timepoints during the first 12 weeks of antitumor necrosis factor therapy', Journal of Rheumatology, 43, pp. 75 - 80, http://dx.doi.org/10.3899/jrheum.150347
,2016, 'AB0344 A Retrospective Non-Interventional Study on The Use of Biologics in The Treatment of Australian Patients with Rheumatoid Arthritis-The Real Study', Annals of the Rheumatic Diseases, 75, pp. 1019.3 - 1020, http://dx.doi.org/10.1136/annrheumdis-2016-eular.4470
,2016, 'AB0368 AC-Cute: An Open-Label Study To Evaluate Non-Progression of Structural Joint Damage in Patients with Moderate To Severe Active Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab', Annals of the Rheumatic Diseases, 75, pp. 1029.2 - 1030, http://dx.doi.org/10.1136/annrheumdis-2016-eular.3780
,2016, 'FRI0521 Reliability of An Omeract Rheumatoid Arthritis Tenosynovitis Scoring System for Wrist and Hand', Annals of the Rheumatic Diseases, 75, pp. 627.3 - 628, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1445
,2016, 'Safety and efficacy of vertebroplasty for acute painful osteoporotic fractures (VAPOUR): a multicentre, randomised, double-blind, placebo-controlled trial', Lancet, 388, pp. 1408 - 1408, http://dx.doi.org/10.1016/S0140-6736(16)31341-1
,2016, 'THU0422 Apremilast Monotherapy as The First Systemic Treatment in DMARD-Naïve Patients with Active Psoriatic Arthritis: 3-Year Treatment Results', Annals of the Rheumatic Diseases, 75, pp. 342.1 - 342, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2405
,2016, 'THU0432 Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated with Long-Term (104-Week) Improvement in Fatigue in Patients with Psoriatic Arthritis: Pooled Results from 3 Phase III, Randomized, Controlled Trials', Annals of the Rheumatic Diseases, 75, pp. 346.1 - 346, http://dx.doi.org/10.1136/annrheumdis-2016-eular.1487
,2016, 'THU0436 A Retrospective Non-Interventional Multi-Centre Study Evaluating Treatment Regimens Used in Psoriatic Arthritis Patients in Australia- The PSA Real Study', Annals of the Rheumatic Diseases, 75, pp. 348.1 - 348, http://dx.doi.org/10.1136/annrheumdis-2016-eular.2099
,2015, 'The longitudinal reliability and responsiveness of the OMERACT Hand Osteoarthritis Magnetic Resonance Imaging Scoring System (HOAMRIS)', Journal of Rheumatology, 42, pp. 2486 - 2491, http://dx.doi.org/10.3899/jrheum.140983
,2015, 'The OMERACT MRI in arthritis working group - Update on status and future research priorities', Journal of Rheumatology, 42, pp. 2470 - 2472, http://dx.doi.org/10.3899/jrheum.141248
,2015, 'Validation of the OMERACT magnetic resonance imaging joint space narrowing score for the wrist in a multireader longitudinal trial', Journal of Rheumatology, 42, pp. 2480 - 2485, http://dx.doi.org/10.3899/jrheum.141009
,2015, 'Validation of the OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) for the hand and foot in a randomized placebo-controlled trial', Journal of Rheumatology, 42, pp. 2473 - 2479, http://dx.doi.org/10.3899/jrheum.141010
,2015, 'Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial.', Lancet, 386, pp. 1137 - 1146, http://dx.doi.org/10.1016/S0140-6736(15)61134-5
,2015, 'Patients with rheumatoid arthritis in the Australian OPAL cohort show significant improvement in disease activity over 5 years: A multicenter observational study', Journal of Rheumatology, 42, pp. 1603 - 1609, http://dx.doi.org/10.3899/jrheum.141575
,2015, 'Utility of in-office extremity magnetic resonance imaging in rheumatology', Indian Journal of Rheumatology, 10, pp. 140 - 146, http://dx.doi.org/10.1016/j.injr.2015.06.002
,2015, 'A NOVEL, FULLY 3-DIMENSIONAL DYNAMIC CONTRAST MRI METHOD IN THE HAND REVEALS DETAILS OF SYNOVIAL INFLAMMATION AND PROVIDES A SENSITIVE MEASURE OF CHANGE', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 879 - 879, http://dx.doi.org/10.1136/annrheumdis-2015-eular.6400
,2015, 'BASELINE MRI/CRP AS PREDICTORS OF RESPONSE TO ETANERCEPT IN THE MANAGEMENT OF PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 752 - 752, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2254
,2015, 'CAN WE STOP USING CONTRAST IN RA MRI CLINICAL TRIALS? QUANTITATIVE MRI DEMONSTRATES SIMILAR RESPONSIVENESS FOR CONTRAST AND CONTRAST-FREE SYNOVITIS ASSESSMENT', ANNALS OF THE RHEUMATIC DISEASES, 74, pp. 873 - 873, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4884
,2015, 'Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): Study protocol for a randomized controlled trial', Trials, 16, http://dx.doi.org/10.1186/s13063-015-0671-8
,2015, 'SAT0562 Long-Term (104-Week) Efficacy and Safety of Apremilast Monotherapy in Dmard-Naïve Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial and Open-Label Extension (Palace 4)', Annals of the Rheumatic Diseases, 74, pp. 863.2 - 864, http://dx.doi.org/10.1136/annrheumdis-2015-eular.2896
,2015, 'THU0146 Dispensing of Biologics Prescribed for the Treatment of Rheumatoid Arthritis in the Australian Population', Annals of the Rheumatic Diseases, 74, pp. 246.2 - 247, http://dx.doi.org/10.1136/annrheumdis-2015-eular.4326
,2014, 'How well do patients understand written instructions?: health literacy assessment in rural and urban rheumatology outpatients', Medicine, 93, pp. e129, http://dx.doi.org/10.1097/MD.0000000000000129
,2014, 'RHEUMATOID ARTHRITIS PATIENTS IN AUSTRALIAN DATABASE SHOW SIGNIFICANT IMPROVEMENT IN DISEASE ACTIVITY OVER 5 YEARS', ANNALS OF THE RHEUMATIC DISEASES, 73, pp. 883 - 883, http://dx.doi.org/10.1136/annrheumdis-2014-eular.4834
,2014, 'No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: Results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial', Rheumatology (United Kingdom), 53, pp. 746 - 756, http://dx.doi.org/10.1093/rheumatology/ket426
,2014, 'Ultrasound versus high-field magnetic resonance imaging in rheumatoid arthritis', Clinical and Experimental Rheumatology, 32, pp. 99 - 105
,2014, 'Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity', Arthritis Care and Research, 66, pp. 190 - 196, http://dx.doi.org/10.1002/acr.22108
,2014, 'Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: Results from a followup MRI Study of 254 patients in clinical remission or low disease activity', Journal of Rheumatology, 41, pp. 398 - 406, http://dx.doi.org/10.3899/jrheum.131088
,2014, 'The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: Intrareader and interreader reliability and agreement with computed tomography and conventional radiography', Journal of Rheumatology, 41, pp. 392 - 397, http://dx.doi.org/10.3899/jrheum.131087
,2014, 'Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA)', International Journal of Rheumatic Diseases, 17, pp. 548 - 556, http://dx.doi.org/10.1111/1756-185X.12358
,2014, 'Iterative development and reliability of the OMERACT Hand Osteoarthritis MRI Scoring System', Journal of Rheumatology, 41, pp. 386 - 391, http://dx.doi.org/10.3899/jrheum.131086
,2014, 'Pattern of bone erosion and bone proliferation in psoriatic arthritis hands: A high-resolution computed tomography and radiography follow-up study during adalimumab therapy', Scandinavian Journal of Rheumatology, 43, pp. 202 - 208, http://dx.doi.org/10.3109/03009742.2013.835865
,2014, 'Update on the OMERACT magnetic resonance imaging task force: Research and future directions', Journal of Rheumatology, 41, pp. 383 - 385, http://dx.doi.org/10.3899/jrheum.131085
,2014, 'SAT0377 Long-Term Safety and Tolerability of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: A Phase 3, Randomized, Controlled Trial', Annals of the Rheumatic Diseases, 73, pp. 730.2 - 730, http://dx.doi.org/10.1136/annrheumdis-2014-eular.1575
,2014, 'SAT0382 Palace 4, A Phase 3, Randomized, Controlled TRIAL of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Treatment of Psoriatic Arthritis: Long-Term (52-WEEK) Improvements in Physical Function', Annals of the Rheumatic Diseases, 73, pp. 732.1 - 732, http://dx.doi.org/10.1136/annrheumdis-2014-eular.1096
,2014, 'SAT0389 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-Week) Improvements in Enthesitis and Dactylitis in Patients with Psoriatic Arthritis: Results from the Palace 4 Phase 3, Randomized, Controlled Trial', Annals of the Rheumatic Diseases, 73, pp. 735.1 - 735, http://dx.doi.org/10.1136/annrheumdis-2014-eular.1574
,